GE HealthCare Technologies Inc. $GEHC Position Lifted by Aberdeen Group plc

GE HealthCare Technologies logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Aberdeen Group increased its GE HealthCare stake by 247.4% in the third quarter, adding 396,044 shares to hold 556,124 shares valued at about $36.4 million. Institutional investors and hedge funds collectively own 82.06% of the stock.
  • GE HealthCare reported quarterly EPS of $1.34, beating estimates of $1.20, while revenue of $5.51 billion also topped forecasts and rose 7.2% year over year.
  • Analysts’ consensus rating is “Moderate Buy”, with an average price target of $82.17. The company also raised its quarterly dividend from $0.035 to $0.04 per share.
  • Five stocks we like better than GE HealthCare Technologies.

Aberdeen Group plc raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 247.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 556,124 shares of the company's stock after purchasing an additional 396,044 shares during the period. Aberdeen Group plc owned approximately 0.12% of GE HealthCare Technologies worth $36,354,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of GEHC. State Street Corp boosted its position in shares of GE HealthCare Technologies by 1.6% during the second quarter. State Street Corp now owns 20,861,566 shares of the company's stock worth $1,335,349,000 after purchasing an additional 323,090 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC lifted its holdings in GE HealthCare Technologies by 13.2% during the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 13,455,814 shares of the company's stock worth $861,307,000 after acquiring an additional 1,571,226 shares in the last quarter. Dimensional Fund Advisors LP lifted its holdings in GE HealthCare Technologies by 2.0% during the first quarter. Dimensional Fund Advisors LP now owns 5,399,439 shares of the company's stock worth $384,219,000 after acquiring an additional 105,995 shares in the last quarter. Van ECK Associates Corp grew its stake in GE HealthCare Technologies by 4.1% in the second quarter. Van ECK Associates Corp now owns 4,482,631 shares of the company's stock valued at $286,933,000 after acquiring an additional 177,028 shares during the period. Finally, Mizuho Markets Cayman LP grew its stake in GE HealthCare Technologies by 173.2% in the first quarter. Mizuho Markets Cayman LP now owns 3,068,500 shares of the company's stock valued at $218,416,000 after acquiring an additional 1,945,500 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have recently commented on GEHC. UBS Group raised their price target on GE HealthCare Technologies from $73.00 to $80.00 and gave the stock a "neutral" rating in a research report on Tuesday, November 3rd. BTIG Research increased their target price on GE HealthCare Technologies from $75.00 to $83.00 and gave the stock a "buy" rating in a research note on Wednesday, October 28th. Wells Fargo & Company increased their target price on GE HealthCare Technologies from $75.00 to $85.00 and gave the stock an "overweight" rating in a research note on Thursday, July 30th. Zacks Research upgraded shares of GE HealthCare Technologies from a "strong sell" rating to a "hold" rating in a report on Tuesday, August 11th. Finally, Evercore reaffirmed an "outperform" rating and issued a $84.00 price target on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. Twelve analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $82.17.

View Our Latest Analysis on GEHC

GE HealthCare Technologies Trading Down 0.1%

NASDAQ GEHC opened at $82.96 on Tuesday. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77. The company has a current ratio of 1.30, a quick ratio of 1.01 and a debt-to-equity ratio of 0.86. The stock has a 50 day moving average of $70.83 and a 200-day moving average of $70.13. The company has a market cap of $37.51 billion, a PE ratio of 17.50, a PEG ratio of 2.06 and a beta of 0.65.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Wednesday, October 28th. The company reported $1.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.20 by $0.14. The firm had revenue of $5.51 billion for the quarter, compared to analyst estimates of $5.35 billion. GE HealthCare Technologies had a net margin of 9.96% and a return on equity of 20.45%. The company's quarterly revenue was up 7.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.07 earnings per share. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 5.02 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 13th. Investors of record on Friday, October 23rd were paid a $0.04 dividend. This is an increase from GE HealthCare Technologies's previous quarterly dividend of $0.0350. The ex-dividend date was Friday, October 23rd. This represents a $0.16 annualized dividend and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.38%.

GE HealthCare Technologies Profile

(Free Report)

GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company's products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.

Featured Stories

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in GE HealthCare Technologies Right Now?

Before you consider GE HealthCare Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.

While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines